Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR/ARHP Annual Meeting 2012: Use a Combination of Tests, Patient History, and Physical Exam when Assessing Myopathies

Susan Bernstein  |  Issue: April 2013  |  April 1, 2013

Value of EMG Tests

EMG tests assess nerve and muscle function, but in diagnosing myopathy, they should be an extension of the clinical examination, said Devon Rubin, MD, director of the neurophysiology laboratory at Mayo Clinic in Jacksonville, Fla. An EMG should be performed by someone trained in neuromuscular conditions to avoid false-positive or false-negative diagnoses, he said.

EMG can aid physicians at various stages of patient evaluation, Dr. Rubin said, including initial diagnosis, etiology, narrowing differential diagnosis, determining which muscle to biopsy, or to assess response to treatments. EMG must contain both a nerve conduction study and a needle examination. The nerve conduction study electrostimulates the nerve and measures the potential action downstream, Dr. Rubin noted. It’s performed at several different spots to assess amplitude, distal latency, and conduction velocity.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Nerve conduction studies usually are normal in myopathies, he said. This test is more useful in diagnosing carpal tunnel syndrome, peripheral neuropathy, and neuromuscular junction disorders like myasthenia gravis. Therefore, the most important component of EMG is the needle exam. This test measures both resting and contracted muscle, Dr. Rubin said. Several muscles usually are tested, depending on the distribution of the patient’s muscle weakness. The test is not painful, he added.

In patients with myositis, the needle exam may produce fibrillation potentials, marked by audible “ticking” sounds in resting muscles that would normally present without them, Dr. Rubin demonstrated. This may be a sign that muscle fibers are denervated, he said. Fibrillation potentials are reported in 45% to 80% of patients with inflammatory myopathies, he said. Myotonic discharges, waves of sound that resemble dive-bombing aircraft when the patient’s muscle is at rest, and motor unit potential changes are also clues that myopathies may be present.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Muscle Biopsies

If EMG results indicate possible myopathy, the next step is a muscle biopsy, said David Lacomis, MD, professor of neurology and pathology chief in the division of neuromuscular diseases at the University of Pittsburgh Medical Center. “I would encourage you to make sure that the pathologist is provided with the clinical history, as this will impact how many stains and what stains the pathologist will look for” to confirm myopathy, he said.

There are many factors involved in acquiring an accurate reading of the biopsy, including specimen quality and even if it was mishandled or sent to the lab late in the day, Dr. Lacomis noted. “If your lab is not looking at frozen muscle tissue, then that is below the standard of care.” Examine the pathology report for comments about the specimen quality, he suggested.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsMeeting Reports Tagged with:ACR/ARHP Annual MeetingautoantibodiesDiagnosisMyopathiesneuromuscular disease

Related Articles

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

    Autoantibodies in Autoimmune Myopathy

    Autoantibodies in Autoimmune Myopathy

    September 18, 2017

    In recent years, scientists and clinicians have learned a great deal about autoantibodies occurring in idiopathic inflammatory myopathies (IIMs). These new discoveries have reshaped our understanding of distinct clinical pheno­types in IIMs. Scientists continue to learn more about how these auto­antibodies shape pathophysiology, diagnosis, disease monitoring, prognosis and optimum treatment. Moving forward, these autoantibodies will…

    AJPhoto / Science Source

    Tips for Diagnosing Metabolic Myopathies

    September 17, 2019

    When evaluating patients with possible myopathic symptoms, rheumatologists must consider a rare, but important, group of inherited disorders: the metabolic myopathies. However, their diagnosis often remains a challenge. Early recognition of these primary metabolic myopathies is essential to help prevent disease morbidity and mortality from rhabdomyolysis. Here, we focus on the metabolic myopathies that present…

    Diagnosis: Myopathy

    July 1, 2009

    Presentation and evaluation of metabolic causes

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences